Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Xenotransplantation
Journal
Overview
Identity
Overview
Publication Venue For
Deceased humans and living pigs as sources of kidneys for clinical transplantation—Can they be compared?
2021
Potential roles of mesenchymal stromal cells in islet allo- and xenotransplantation for type 1 diabetes mellitus
2021
The first clinical trial—Kidney or heart?
. 28.
2021
Efficacy of ATG and Rituximab in capuchin monkeys (a New World monkey)–An in vitro study relevant to xenotransplantation
. 27.
2020
Immunosuppressive and metabolic agents that influence allo- and xenograft survival by in vivo expansion of T regulatory cells
. 27.
2020
Extracellular histones and xenotransplantation
. 27.
2020
Fluid intake and output in baboons
. 27.
2020
How the COVID-19 pandemic may impact public support for clinical xenotransplantation in the United States?
. 27.
2020
The final obstacle to successful pre-clinical xenotransplantation?
. 27.
2020
The human T-cell proliferative response to triple-knockout pig cells in mixed lymphocyte reaction
. 27.
2020
What will be the cost of a genetically-engineered pig organ for clinical xenotransplantation?
. 27.
2020
Meta-analysis of public perception toward xenotransplantation
. 27.
2020
Clinical trials of xenotransplantation: The need for a worldwide registry
. 27.
2020
Recommendations to the IRB review process in preparation of xenotransplantation clinical trials
. 27.
2020
Growth hormone receptor knockout: Relevance to xenotransplantation
2020
Racial differences in attitudes to clinical pig organ Xenotransplantation
2020
The problem of the “4th xenoantigen” after pig organ transplantation in non-human primates may be overcome by expression of human “protective” proteins
2020
Decellularization methods for developing porcine corneal xenografts and future perspectives
. 26.
2019
Downregulation of Gabarapl1 significantly attenuates antibody binding to porcine aortic endothelial cells
. 26.
2019
Selective inhibition of cyclooxygenase-2 protects porcine aortic endothelial cells from human antibody-mediated complement-dependent cytotoxicity
. 26.
2019
A potential role of TLR2 in xenograft rejection of porcine iliac endothelial cells: An in vitro study
. 26.
2019
Circulating pig-specific DNA as a novel biomarker for monitoring xenograft rejection
. 26.
2019
Justification of specific genetic modifications in pigs for clinical organ xenotransplantation
. 26.
2019
The complex functioning of the complement system in xenotransplantation
. 26.
2019
The “Baby Fae” baboon heart transplant—Potential cause of rejection
. 26.
2019
A review of pig liver xenotransplantation: Current problems and recent progress
. 26.
2019
Carbohydrate antigen expression and anti-pig antibodies in New World capuchin monkeys: Relevance to studies of xenotransplantation
. 26.
2019
Cover Image, Volume 26, Issue 3
. 26.
2019
Financial support for xenotransplantation research
. 26.
2019
Life-supporting porcine cardiac xenotransplantation: The Munich study
. 26.
2019
Potential pathological role of pro-inflammatory cytokines (IL-6, TNF-α, and IL-17) in xenotransplantation
. 26.
2019
Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation
. 26.
2019
Episodes of hypovolemia/dehydration in baboons with pig kidney transplants: A new syndrome of clinical importance?
. 26.
2019
Oscar Salvatierra, Jr, MD (1935-2019)
. 26:e12521.
2019
Will donor-derived neoplasia be problematic after clinical pig organ or cell xenotransplantation?
. 26.
2019
Circulating miRNA or circulating DNA—Potential biomarkers for organ transplant rejection
. 26.
2019
An approach to induction of tolerance to pig cardiac xenografts in neonates
. 25.
2018
Porcine IL-6, IL-1β, and TNF-α regulate the expression of pro-inflammatory-related genes and tissue factor in human umbilical vein endothelial cells
. 25.
2018
Donor-derived infections and infectious risk in xenotransplantation and allotransplantation
. 25.
2018
20th Anniversary of IXA, 1998–2018
. 25.
2018
Is sensitization to pig antigens detrimental to subsequent allotransplantation?
. 25.
2018
Jewish, Christian and Muslim theological perspectives about xenotransplantation
. 25.
2018
Cover Image, Volume 25, Issue 2
. 25:e12397-e12397.
2018
The Sda and Cad glycan antigens and their glycosyltransferase, β1,4GalNAcT-II, in xenotransplantation
. 25.
2018
The Natural Anti-Gal Antibody as Foe Turned Friend in MedicineUri GaliliPhD, Academic Press (an imprint of Elsevier), London, 2018. pp. 1-300. Price US$95.50.
. 25:e12364-e12364.
2018
Low anti-pig antibody levels are key to the success of solid organ xenotransplantation: But is this sufficient?
. 24.
2017
Miscellaneous
. 24.
2017
David J. G. White, PhD, FRCPath
. 24.
2017
Angiopoietin-1 and angiopoietin-2 protect porcine iliac endothelial cells from human antibody-mediated complement-dependent cytotoxicity through phosphatidylinositide 3-kinase/AKT pathway activation
. 24.
2017
Financial aspects of organ procurement from deceased donors in the USA—Relevance to xenotransplantation
. 24.
2017
The impact of serum incubation time on IgM/IgG binding to porcine aortic endothelial cells
. 24.
2017
Early clinical xenotransplantation experiences—An interview with Thomas E. Starzl, MD, PhD
. 24.
2017
Human IL-6, IL-17, IL-1β, and TNF-α differently regulate the expression of pro-inflammatory related genes, tissue factor, and swine leukocyte antigen class I in porcine aortic endothelial cells
. 24.
2017
Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts
. 24.
2017
Therapeutic regulation of systemic inflammation in xenograft recipients
. 24.
2017
Thomas E. Starzl, MD, PhD, 1926-2017
. 24.
2017
Transplantation of hepatocytes from genetically engineered pigs into baboons
. 24.
2017
Development of retrocorneal membrane following pig-to-monkey penetrating keratoplasty
. 24.
2017
Initial study of α1,3-galactosyltransferase gene-knockout/CD46 pig full-thickness corneal xenografts in rhesus monkeys
. 24.
2017
Klotho attenuated antibody-mediated porcine endothelial cell activation and injury
. 24.
2017
Safe use of anti-CD154 monoclonal antibody in pig islet xenotransplantation in monkeys
. 24.
2017
Human antibody recognition of xenogeneic antigens (NeuGc and Gal) on porcine heart valves: could genetically modified pig heart valves reduce structural valve deterioration?
. 23:370-380.
2016
Psychosocial challenges of xenotransplantation: the need for a multidisciplinary, religious, and cultural dialogue
. 23:335-337.
2016
Is successful orthotopic heart transplantation in the pig-to-non-human primate model required before proceeding to a clinical trial?
. 23:328-329.
2016
Thyroid hormone: relevance to xenotransplantation
. 23:293-299.
2016
Initial in vitro studies on tissues and cells from GTKO/CD46/NeuGcKO pigs
. 23:137-150.
2016
The pathobiology of pig-to-primate xenotransplantation: A historical review
. 23:83-105.
2016
First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 2b: Genetically modified source pigs
. 23:32-37.
2016
First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Chapter 4: Pre-clinical efficacy and complication data required to justify a clinical trial
. 23:46-52.
2016
First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes - Executive summary
. 23:3-13.
2016
Transgenic expression of human CD46: Does it reduce the primate T-cell response to pig endothelial cells?
. 22:487-489.
2015
Further evidence for sustained systemic inflammation in xenograft recipients (SIXR)
. 22:399-405.
2015
Experimental hepatocyte xenotransplantation - A comprehensive review of the literature
. 22:239-248.
2015
Pig kidney graft survival in a baboon for 136 days: Longest life-supporting organ graft survival to date
. 22:302-309.
2015
Characterization of the cellular infiltrate in bioprosthetic heart valves explanted from patients with structural valve deterioration
. 22:406-407.
2015
Early graft failure of GalTKO pig organs in baboons is reduced by expression of a human complement pathway-regulatory protein
. 22:310-316.
2015
Expression of NeuGc on pig heart valves
. 22:153-154.
2015
Glucose metabolism in pigs expressing human genes under an insulin promoter
. 22:70-79.
2015
In vitro exposure of pig neonatal isletlike cell clusters to human blood
. 22:317-324.
2015
Islet xenotransplantation: What is the optimal age of the islet-source pig?
. 22:7-19.
2015
Pig-to-baboon heterotopic heart transplantation - Exploratory preliminary experience with pigs transgenic for human thrombomodulin and comparison of three costimulation blockade-based regimens
. 22:211-220.
2015
Systemic inflammation in xenograft recipients precedes activation of coagulation
. 22:32-47.
2015
Development of a consensus protocol to quantify primate anti-non-Gal xenoreactive antibodies using pig aortic endothelial cells
. 21:555-566.
2014
Progress in pig-to-non-human primate transplantation models (1998-2013): A comprehensive review of the literature
. 21:397-419.
2014
The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of xenocorneal transplantation
. 21:420-430.
2014
Tribute to Carl-Gustav Groth (1933-2014), first president of the International Xenotransplantation Association
. 21:97-98.
2014
A milestone in xenotransplantation research
. 21:13-15.
2014
Are there advantages in the use of specific pathogen-free baboons in pig organ xenotransplantation models?
. 21:287-290.
2014
Bioprosthetic heart valves of the future
. 21:1-10.
2014
Corneal blindness and xenotransplantation
. 21:99-114.
2014
Plasma free triiodothyronine (fT3) levels in baboons undergoing pig organ transplantation: Relevance to early recovery of organ function
. 21:582-583.
2014
Regulation of human platelet aggregation by genetically modified pig endothelial cells and thrombin inhibition
. 21:72-83.
2014
Role of P-selectin and P-selectin glycoprotein ligand-1 interaction in the induction of tissue factor expression on human platelets after incubation with porcine aortic endothelial cells
. 21:16-24.
2014
The role of platelets in coagulation dysfunction in xenotransplantation, and therapeutic options
. 21:201-220.
2014
Minimal effect of bortezomib in reducing anti-pig antibodies in human leukocyte antigen-sensitized patients: A pilot study
. 20:429-437.
2013
Histopathologic insights into the mechanism of anti-non-Gal antibody-mediated pig cardiac xenograft rejection
. 20:292-307.
2013
Toward clinical islet xenotransplantation - Are revisions to the IXA guidelines warranted?
. 20:68-74.
2013
Commentary: Limitations of the pig-to-non-human primate islet transplantation model
. 20:2-4.
2013
Comparison of hematologic, biochemical, and coagulation parameters in α1,3-galactosyltransferase gene-knockout pigs, wild-type pigs, and four primate species
. 19:342-354.
2012
Anti-gal antibodies in α1,3-galactosyltransferase gene-knockout pigs
. 19:305-310.
2012
Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation
. 19:273-285.
2012
Human T-cell proliferation in response to thrombin-activated GTKO pig endothelial cells
. 19:311-316.
2012
Costimulation blockade in pig artery patch xenotransplantation - A simple model to monitor the adaptive immune response in nonhuman primates
. 19:221-232.
2012
Platelet aggregation in humans and nonhuman primates: Relevance to xenotransplantation
. 19:233-243.
2012
Clinical lung xenotransplantation - What donor genetic modifications may be necessary?
. 19:144-158.
2012
Porcine alanine transaminase after liver allo-and xenotransplantation
. 19:52-55.
2012
The effect of Gal expression on pig cells on the human T-cell xenoresponse
. 19:56-63.
2012
Thrombocytopenia after pig-to-baboon liver xenotransplantation: Where do platelets go?
. 18:320-327.
2011
A record of international meetings on xenotransplantation 1988-2010
. 18:229-231.
2011
Clinical pig liver xenotransplantation: How far do we have to go?
. 18:158-167.
2011
Genetically-modified pig mesenchymal stromal cells: Xenoantigenicity and effect on human T-cell xenoresponses
. 18:183-195.
2011
Multivisceral xenotransplantation-does it have a future?
. 17:418-422.
2010
An in vitro model of pig liver xenotransplantation-pig complement is associated with reduced lysis of wild-type and genetically modified pig cells
. 17:370-378.
2010
The immunology of corneal xenotransplantation: A review of the literature
. 17:338-349.
2010
Outwitting evolution: Honorary Fellowship Lecture
. 17:171-180.
2010
Insulin secretion and glucose metabolism in alpha 1,3-galactosyltransferase knock-out pigs compared to wild-type pigs
. 17:131-139.
2010
Investigation of potential carbohydrate antigen targets for human and baboon antibodies
. 17:197-206.
2010
The potential of genetically-modified pig mesenchymal stromal cells in xenotransplantation
. 17:3-5.
2010
Monitoring of porcine and baboon cytomegalovirus infection in xenotransplantation
. 16:535-536.
2009
Pandemic swine flu 2009: Invited commentary
. 16:463-465.
2009
Production and characterization of transgenic pigs expressing porcine CTLA4-Ig
. 16:477-485.
2009
Current status of xenotransplantation and prospects for clinical application
. 16:263-280.
2009
The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Chapter 4: Pre-clinical efficacy and complication data required to justify a clinical trial
. 16:229-238.
2009
The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes-Executive summary
. 16:196-202.
2009
Invited commentary
. 16:58-60.
2009
Identification of αgal as the major target for human anti-pig antibodies
. 16:47-49.
2009
Islet xenotransplantation: The pig-to-non-human primate model
. 15:104-106.
2008
Erratum: Babesia as a complication of immunosuppression following pig-to-baboon heart transplantation (Xenotransplantation (2007) 14,2, (162-165) DOI: 10.1111/j.1399-3089.2007.00375.x)
. 14:374.
2007
Erratum: The potential of statins in xenotransplantation (Xenotransplantation (2007) 14,2, (100-103) DOI: 10.1111/j.1399-3089.2007.00389. x)
. 14:374.
2007
Rapid loss of intraportally transplanted islets: An overview of pathophysiology and preventive strategies
. 14:288-297.
2007
Acute gastric dilatation after porcine islet transplantation in a cynomolgus monkey - Case history and review of the literature
. 14:265-270.
2007
The pig-to-primate immune response: Relevance for xenotransplantation
. 14:227-235.
2007
The potential of statins in xenotransplantation: Commentary
. 14:100-103.
2007
Babesia as a complication of immunosuppression following pig-to-baboon heart transplantation
. 14:162-165.
2007
Isolation outcome and functional characteristics of young and adult pig pancreatic islets for transplantation studies
. 14:74-82.
2007
Rene Kuss's clinical experience with pig kidney transplantation in 1966 [4]
. 14:93.
2007
Extended coagulation profiles of healthy baboons and of baboons rejecting GT-KO pig heart grafts
. 13:522-528.
2006
Measurement of anti-CD154 monoclonal antibody in primate sera by competitive inhibition ELISA
. 13:566-570.
2006
Selected physiologic compatibilities and incompatibilities between human and porcine organ systems
. 13:488-499.
2006
ABO-incompatible allotransplantation as a basis for clinical xenotransplantation
. 13:390-399.
2006
Antibodies directed to pig non-Gal antigens in naïve and sensitized baboons
. 13:400-407.
2006
Allosensitized humans are at no greater risk of humoral rejection of GT-KO pig organs than other humans
. 13:357-365.
2006
PERV methodology
. 13:171.
2006
Buccal mucosal cell immunohistochemistry: A simple method of determining the ABH phenotype of baboons, monkeys, and pigs
. 13:63-68.
2006
Journal requirements for manuscripts on clinical trials of xenotransplantation
. 13:2.
2006
Letter from the Editors
. 13:1.
2006
Localized myocardial infarction following pig-to-baboon heart transplantation
. 12:489-491.
2005
Reducing Gal expression on the pig organ - A retrospective review
. 12:278-285.
2005
Antibody- and complement-independent phagocytotic and cytolytic activities of human macrophages toward porcine cells
. 12:181-188.
2005
Which patients first? Planning the first clinical trial of xenotransplantation: A case for cardiac bridging
. 12:168-172.
2005
How strong is the T cell response in the pig-to-primate model?
. 12:85-87.
2005
Draft reports for public comment from the US Secretary's Advisory Committee on Xenotransplantation.
. 12:255-257.
2005
Early weaning of piglets fails to exclude porcine lymphotropic herpesvirus
. 12:59-62.
2005
Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons
. 11:416-425.
2004
Bone marrow transplantation from α1,3-galactosyltransferase gene-knockout pigs in baboons
. 11:361-370.
2004
Initial experience with the human anti-human CD154 monoclonal antibody, ABI793, in pig-to-baboon xenotransplantation
. 11:353-360.
2004
Letter to the editor [3]
. 11:380-381.
2004
Letter to the editor [4]
. 11:382.
2004
Pig spleen transplantation induces transient hematopoietic cell chimerism in baboons [2]
. 11:298-300.
2004
Transfusion of pig red blood cells into baboons [1]
. 11:295-297.
2004
Reduction of anti-Galα1,3Gal antibodies by infusion of types 2 and 6 gal trisaccharides conjugated to poly-L-lysine
. 11:210-215.
2004
Xenotransplantation Manuscripts Now Published OnlineEarly
. 11:109.
2004
Absence of humoral and cellular alloreactivity in baboons sensitized to pig antigens
. 11:27-32.
2004
Galα1,3Gal expression on porcine pancreatic islets, testis, spleen, and thymus
. 11:101-106.
2004
In vitro and in vivo investigation of a novel monoclonal antibody to plasma cells (W5 mAb)
. 11:78-90.
2004
Initial investigation of the potential of modified porcine erythrocytes for transfusion in primates
. 11:18-26.
2004
Relative effects of GAL
+
and GAL
low/-
porcine hematopoietic cells on primate platelet aggregation and endothelial cell activation: Implications for the induction of mixed hematopoietic chimerism in the pig-to-primate model
. 11:72-77.
2004
Statement on allogeneic and xenogeneic transplantation by Fifty-Seventh World Health Assembly, 22 May 2004.
. 11:390.
2004
Xenotransplantation: Letter from the Editors
. 11:1.
2004
Pig kidney transplantation in baboons treated intravenously with a bovine serum albumin-Galα1-3Gal conjugate
. 10:606-614.
2003
An investigation of the effect of thalidomide on anti-gal antibody production in baboons
. 10:470-474.
2003
Porcine red blood cells as a source of blood transfusion in humans
. 10:384-386.
2003
Depletion of anti-Gal antibodies by the intravenous infusion of Gal type 2 and 6 glycoconjugates in baboons
. 10:357-367.
2003
Inhibition of baboon platelet aggregation in vitro and in vivo by the garlic derivative, ajoene
. 10:374-379.
2003
6th Congress of the International Xenotransplantation Association
. 10:7-9.
2003
An exploratory investigation of the effect of arsenic trioxide on anti-Gal antibody production in baboons
. 10:80-87.
2003
An investigation of the specificity of induced anti-pig antibodies in baboons
. 10:88-93.
2003
Neurotoxicity of leflunomide in baboons [2]
. 10:187-188.
2003
Promotion of xenogeneic hematopoietic chimerism in rodents by mononuclear phagocyte depletion
. 9:402-409.
2002
Differential expression of Galα1,3Gal epitopes on fetal and adult porcine hematopoietic cells
. 9:297-300.
2002
Anti-Galα1-3Gal IgM and IgG antibody levels in sera of humans and old world non-human primates
. 9:148-154.
2002
Modulation of the in vivo primate anti-Gal response through administration of anti-idiotypic antibodies
. 9:106-114.
2002
Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade
. 9:3-13.
2002
Xenotransplantation: Letter from the editor
. 8:223.
2001
Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: Depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-αGal antibody
. 8:157-171.
2001
Xenotransplantation: Letter from the editor
. 8:81.
2001
Report: International Xenotransplantation Association
. 8:2.
2001
Xenotransplantation: Editorial
. 8:1.
2001
"Literature update 1999, part 3".
. 8:80.
2001
Letter to Editor
. 8:80.
2001
Inhibition of platelet aggregation in baboons: Therapeutic implications for xenotransplantation
. 7:247-257.
2000
Plasma perfusion by apheresis through a Gal immunoaffinity column successfully depletes anti-Gal antibody: Experience with 320 aphereses in baboons
. 7:181-185.
2000
An approach to the control of disease transmission in pig-to-human xenotransplantation
. 7:143-155.
2000
Venular thrombosis is the key event in the pathogenesis of antibody- mediated cardiac rejection
. 7:31-41.
2000
Disordered regulation of coagulation and platelet activation in xenotransplantation
. 7:166-176.
2000
Pig xenogeneic antigen modification with green coffee bean α- galactosidase
. 6:238-248.
1999
Different responses of human anti-HLA and anti-αgal antibody to long- term intravenous immunoglobulin therapy
. 6:181-186.
1999
The problem of anti-pig antibodies in pig-to-primate xenografting: Current and novel methods of depletion and/or suppression of production of anti-pig antibodies
. 6:157-168.
1999
Major carbohydrate epitopes in tissues of domestic and African wild animals of potential interest for xenotransplantation research
. 6:79-89.
1999
Effect of pig-specific cytokines on mobilization of hematopoietic progenitor cells in pigs and on pig bone marrow engraftment in baboons
. 6:17-27.
1999
Intravenous synthetic αgal saccharides delay hyperacute rejection following pig-to-baboon heart transplantation
. 6:36-42.
1999
Lack of variation in αgal expression on lymphocytes in miniature swine of different genotypes
. 6:43-51.
1999
Comparative histopathology of hepatic allografts and xenografts in the nonhuman primate
. 5:197-206.
1998
Depletion of anti-Galα1-3Gal antibody in baboons by specific α-Gal immunoaffinity columns
. 5:122-131.
1998
Pharmacologic immunosuppressive therapy and extracorporeal immunoadsorption in the suppression of anti-αGal antibody in the baboon
. 5:274-283.
1998
Xenoantigens and xenoantibodies
. 5:6-17.
1998
Legal implications of xenotransplantation
. 4:132-139.
1997
Ethical aspects of xenotransplantation of current importance
. 3:264-274.
1996
Investigation of the anti-complement agents, FUT-175 and K76COOH, in discordant xenotransplantation
. 3:237-245.
1996
Manipulation of the anti-αGal antibody-αGal epitope system in experimental discordant xenotransplantation
. 3:102-111.
1996
Ratites (ostrich, emu) as potential heart donors for humans: Immunologic, anatomic, and physiologic considerations
. 3:252-259.
1996
Detection, immunoabsorption, and inhibition of cytotoxic activity of anti‐αGal antibodies using newly developed substances with synthetic Gal α1–3Gal disaccharide epitopes
. 2:98-106.
1995
Inhibition of human anti‐αGal IgG by oligosaccharides derived from porcine stomach mucin
. 2:279-288.
1995
Screening of baboons as potential liver donors for humans
. 2:244-252.
1995
Variability of anti‐αGal antibodies in human serum and their relation to serum cytotoxicity against pig cells
. 1:58-65.
1994
Identity
International Standard Serial Number (issn)
0908-665X
Electronic International Standard Serial Number (eissn)
1399-3089